Table1.

Characteristics of the patients (N =206).

	Baseline (N = 206)	Follow-up (N = 195)
Age, years	53.0 (13.5)
Women, n (%)	155 (75.2)
White, n (%)	105 (51.0)
Black, n (%)	54 (26.2)
Hispanic, n (%)	28 (13.6)
Asian, n (%)	17 (8.2)
Other ethnicity, n (%)	2 (1.0)
Education, years	13.7 (3.0)
Duration of RA, years	10.2 (10.1)
Seropositive, n (%)*	140 (75.7)
Erosive, n (%)†	115 (65.0)
Patient global assessment (0 – 100)	52.8 (25.0)	37.6 (23.1)
Rating scale (0 – 100)	45.0 (25.2)	33.2 (22.0)
Evaluator global assessment (0 – 100)	46.2 (17.5)	27.1 (17.2)
Pain Scale (0 – 100)	58.7 (25.6)	40.7 (26.2)
HAQ (0 – 3)	1.4 (0.7)	1.1 (0.7)
DAS28 using 3 variables	5.3 (1.0)	4.4 (1.1)
DAS28 < 3.2, n (%)	2 (1.0)	39 (20.0)
3.2 ≤ DAS28 ≤ 5.1, n (%)	92 (44.6)	105 (53.8)
DAS28 > 5.1, n (%)	112 (54.4)	51 (26.2)

Values are mean (SD) or n (%).

Values in parentheses after the measures are possible ranges.

RA = rheumatoid arthritis; DAS28 = Disease Activity Score 28; HAQ = Health Assessment Questionnaire.

^*Of 185 with results.

^†Of 177 with results.